Gender trend over time of principal investigators within large Australian cancer clinical trials groups

被引：0
|
作者：
Luong, T. T. V. [1 ]
Ho, C. H. [2 ]
Aedo-Lopez, V. [1 ]
Segelov, E. [1 ]
机构：
[1] Monash Hlth, Monash Canc Ctr, Oncol, Melbourne, Vic, Australia
[2] Monash Univ, Med, Clayton, Vic, Australia
来源：
ANNALS OF ONCOLOGY | 2022年 / 33卷
关键词：
D O I：
10.1016/j.annonc.2022.10.434
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
403P
引用
收藏
页码：S1600 / S1600
页数：1
相关论文
共 26 条
  • [11] Changes in the use of end points in clinical trials for elderly cancer patients over time
    Le Saux, O.
    Falandry, C.
    Gan, H. K.
    You, B.
    Freyer, G.
    Peron, J.
    ANNALS OF ONCOLOGY, 2017, 28 (10) : 2606 - 2611
  • [12] Editorial: "Humanized" Large Animal Cancer Models: Accelerating Time and Effectiveness of Clinical Trials
    Schachtschneider, Kyle M.
    Jungersen, Gregers
    Schook, Lawrence B.
    Shanmuganayagam, Dhanansayan
    FRONTIERS IN ONCOLOGY, 2019, 9
  • [13] Changes in the Use of Comprehensive Geriatric Assessment in Clinical Trials for Older Patients with Cancer over Time
    Le Saux, Olivia
    Falandry, Claire
    Gan, Hui K.
    You, Benoit
    Freyer, Gilles
    Peron, Julien
    ONCOLOGIST, 2019, 24 (08): : 1089 - 1094
  • [14] FEASIBILITY AND ACCEPTABILITY OF MINIMAL MODELING VALUE OF INFORMATION ANA LYSES FOR REAL-TIME PRIORITIZATION DECISIONS WITHIN A LARGE CANCER CLINICAL TRIALS COOPERATIVE GROUP
    Bennette, C. S.
    Veenstra, D. L.
    Basu, A.
    Ramsey, S.
    Carlson, J. J.
    VALUE IN HEALTH, 2015, 18 (03) : A21 - A21
  • [15] Development and Evaluation of an Approach to Using Value of Information Analyses for Real-Time Prioritization Decisions Within SWOG, a Large Cancer Clinical Trials Cooperative Group
    Bennette, Caroline S.
    Veenstra, David L.
    Basu, Anirban
    Baker, Laurence H.
    Ramsey, Scott D.
    Carlson, Josh J.
    MEDICAL DECISION MAKING, 2016, 36 (05) : 641 - 651
  • [16] Value of information analyses for real-time prioritization decisions within a cancer clinical trials cooperative group
    Bennette, Caroline Savage
    Ramsey, Scott David
    Veenstra, David Leroy
    Basu, Anirban
    Carlson, Josh John
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [17] Has the quality of health-related quality of life reporting in cancer clinical trials improved over time? Towards bridging the gap with clinical decision making
    Efficace, F.
    Osoba, D.
    Gotay, C.
    Sprangers, M.
    Coens, C.
    Bottomley, A.
    ANNALS OF ONCOLOGY, 2007, 18 (04) : 775 - 781
  • [18] Changes in Early and Late Treatment Outcomes Over Time in Localized Prostate Cancer: A Meta-Analysis on Phase-3 Clinical Trials
    Jiang, T.
    Markovic, D.
    Patel, J.
    Juarez, J. E.
    Shabsovich, D.
    Rettig, M.
    Reiter, R. E.
    Nickols, N. G.
    Zaorsky, N. G.
    Spratt, D. E.
    Steinberg, M. L.
    Elashoff, D. A.
    Kishan, A. U.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E894 - E894
  • [19] Analysis of survival differences over time and between countries in three trials within the nordic myeloma study group.: Impact of international clinical collaboration on treatment and outcome
    Johnsen, H. E.
    Hjorth, M.
    Lenhoff, S.
    Roer, O.
    Klausen, T. W.
    Holmberg, E.
    Gisselo, C. G.
    Nielsen, J. L.
    Storm, H. H.
    Waage, A.
    Wisloff, F.
    Giemsing, P.
    Westin, J.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 (06): : 208 - 209
  • [20] Trends in progression-free survival (PFS) and time to progression (TTP) over time within first-line aromatase inhibitors trials in hormone receptor-positive advanced breast cancer
    Reinert, T.
    Debiasi, M.
    Bines, J.
    Barrios, C. H.
    BREAST CANCER RESEARCH AND TREATMENT, 2018, 168 (02) : 457 - 465
123